Cargando…
Mesenchymal stem cell therapy for advanced liver cirrhosis: A case report
Mesenchymal stem cell (MSC) transplant may offer an alternative to liver transplantation in patients with end‐stage liver disease. However, its efficacy remains uncertain. MSC was performed on a 50‐year‐old male with decompensated (Child‐Turcotte‐Pugh grade C) alcoholic liver cirrhosis due to an abs...
Autores principales: | Rajaram, Ruveena, Subramani, Baskar, Abdullah, Basri J J, Mahadeva, Sanjiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206997/ https://www.ncbi.nlm.nih.gov/pubmed/30483553 http://dx.doi.org/10.1002/jgh3.12027 |
Ejemplares similares
-
Common musculoskeletal disorders in chronic liver disease patients
por: Ranjan, Rajat, et al.
Publicado: (2021) -
Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
por: Cao, Yan, et al.
Publicado: (2020) -
Anthropometric, biochemical and clinical assessment of malnutrition in Malaysian patients with advanced cirrhosis
por: Tai, Mei-Ling S, et al.
Publicado: (2010) -
Hydroxyurea associated ileocecal valve ulcer: evidence for causality
por: Jayaraman, Thevaraajan, et al.
Publicado: (2021) -
Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis
por: Su, Dong-Na, et al.
Publicado: (2020)